Advertisement
Journal Home
Search for

Volume 55, Issue 4, Pages 378-385 (July 2010)


View previous. 5 of 10 View next.

Drug-induced Optic Neuropathy—TB or Not TB

Monika Pradhan, MS, MRCOphth12, Dianne Sharp, FRANZCO1, Stephen Best, FRANZCO1, Andrea Vincent, FRANZCO12Corresponding Author Informationemail address, Michael Vaphiades, DO3

published online 18 January 2010.

Abstract 

Autosomal dominant optic atrophy is an inherited optic neuropathy manifesting with variable penetrance and expressivity. Other genetic and environmental factors are postulated to contribute to more marked visual loss in some affected individuals. Optic neuropathy is also a known adverse effect of ethambutol therapy for tuberculosis. This case report demonstrates an atypical presentation of ethambutol toxicity, with progressive profound loss of vision despite drug cessation. A subsequent diagnosis of autosomal dominant optic atrophy was made when the proband's sons presented with mild visual disturbances and color vision defects, confirmed with electrophysiology and OPA1 gene mutational analysis. This case emphasizes the importance of avoiding potentially neurotoxic therapy in predisposed individuals and the influence of environmental factors in patients with inherited optic neuropathies.

Peter Savino and Helen Danesh-Meyer, Editors

1 Department of Ophthalmology, National Eye Centre, University of Auckland, New Zealand

2 Department of Ophthalmology, Greenlane Clinical Centre, Auckland District Health Board, New Zealand

3 Department of Ophthalmology, University of Alabama, Birmingham, Alabama, USA

Corresponding Author InformationReprint address: Dr Andrea Vincent, Department of Ophthalmology, University of Auckland, Private Bag 92019, Auckland, New Zealand.

 The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(09)00269-0

doi:10.1016/j.survophthal.2009.10.005


View previous. 5 of 10 View next.

Advertisement